Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Chloasma

Synonyms: Melasma, Mask of pregnancy, Chloasma Medicamentosum

Chloasma comes from the Greek chloazein, to be green. It is considered to be something of a misnomer, and many dermatologist prefer the term melasma (melas is Greek for black). The pathophysiology is largely unknown but many differences have been noted between melasma and normal skin. There is, for example, an increase in the level of melanin, large numbers of melanocytes and melanosomes, and increased synthesis of tyrosinase.1

Epidemiology

The exact incidence of chloasma is unknown, but it is a common condition.There is a female to male predilection, with a ratio of 9:1.2

Risk Factors

These include:
Dark skin - it is common in Asians and Hispanics.2
Hormonal - chloasma occurs commonly in pregnancy. One study in Iran found a prevalence among 400 pregnant patients of 15.8%.3 It is rare before puberty and is commonest in women during their reproductive years.2 It is linked to use of oral contraceptives.4 One study of patients with chloasma found that the frequency of thyroid disorders was four times greater compared to a control group.5
Sun exposure - this is a well established risk factor.4 Chloasma occurs in sun-exposed areas of the skin.2
Genetics - 30% of patients report a positive family history, and identical twins with chloasma have been reported.2
AIDS - one study reported a group of AIDS patients who developed chloasma-like hyperpigmentation of the face.

Presentation2

Patients usually complain of gradual onset areas of dark skin. The colour may vary from tan to brown, but may be black or have a bluish tinge. The distribution is usually symmetrical. Three patterns are commonly seen - centrofacial, malar or mandibular.

Differential Diagnosis2
  • Addison Disease
  • Drug-Induced Photosensitivity
  • Lupus Erythematosus, Discoid
  • Mastocytosis (mast cell proliferation and accumulation within various organs, most commonly the skin)
  • Poikiloderma of Civatte (erythema associated with a mottled pigmentation seen on the sides of the neck, more commonly in women)
Investigations2

Wood's light helps to locate the pigmentation in the dermis or epidermis. In many cases, it is found in both locations.2

Management

Chloasma is a difficult condition to manage, as sunlight is a considerable aggravating factor and it is difficult to prevent exposure even with high factor protection creams.
A variety of treatment approaches have been tried. The best seems to be the use of lightening agents. Hydroxyquinone 4% is the commonest used.6 Sometimes a peeling agent such as glycolic acid is added.7 Other lightening agents that have been tried include tretinoic acid, ascorbic acid, and azelaic acid either alone or in combination. None seem to be superior to 4% hydroxyquinone.2Laser treatment and intense pulse light therapy is also sometimes employed to hasten resolution.6

Prognosis

Most cases resolve eventually, but can take a long time to do so. Continued exposure to sunlight tends to hamper treatment and lead to recurrence. Resolution will also take longer in patients with extensive dermal melanin compared to those in whom pigmentation is mainly in the epidermal layer.2


Document References
  1. Victor FC, Gelber J, Rao B; Melasma: a review. J Cutan Med Surg. 2004 Mar-Apr;8(2):97-102. Epub 2004 May 4. [abstract]
  2. Montemarano A; Melasma eMedicine.com 2006
  3. Moin A, Jabery Z, Fallah N; Prevalence and awareness of melasma during pregnancy. Int J Dermatol. 2006 Mar;45(3):285-8. [abstract]
  4. Foldes EG; Pharmaceutical effect of contraceptive pills on the skin. Int J Clin Pharmacol Ther Toxicol. 1988 Jul;26(7):356-9. [abstract]
  5. Lutfi RJ, Fridmanis M, Misiunas AL, et al; Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985 Jul;61(1):28-31. [abstract]
  6. Gupta AK, Gover MD, Nouri K, et al; The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006 Dec;55(6):1048-65. Epub 2006 Sep 28. [abstract]
  7. Guevara IL, Pandya AG; Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int J Dermatol. 2003 Dec;42(12):966-72. [abstract]
Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1946
Document Version: 20
DocRef: bgp2152
Last Updated: 6 Dec 2006
Review Date: 5 Dec 2008
Patient UK Current Health News








Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>








Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page